Advertisement

Magnesium and the obstetric anaesthetist

Published:November 26, 2012DOI:https://doi.org/10.1016/j.ijoa.2012.10.003

      Abstract

      Magnesium is one of the most abundant cations in the human body. It is utilised extensively within the medical world and its role in the treatment of various conditions in both mother and fetus is increasing. This review focuses on the importance of magnesium for the obstetric anaesthetist and looks at the most recent evidence surrounding its use in hypertensive disorders of pregnancy, neuroprotection of the premature infant and the expanding role of magnesium as an analgesic and adjunct to anaesthesia.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Silverman R.A.
        • Osborn H.
        • Runge J.
        • et al.
        IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial.
        Chest. 2002; 122: 489-497
        • Seller R.H.
        • Cangiano J.
        • Kim K.E.
        • et al.
        Digitalis toxicity and hypomagnesemia.
        Am Heart J. 1970; 79: 57-68
        • Thel M.C.
        • Armstrong A.L.
        • McNulty S.E.
        • Califf R.M.
        • O’Connor C.M.
        Randomised trial of magnesium in in-hospital cardiac arrest.
        Lancet. 1997; 350: 1272-1276
        • James M.F.
        • Cronje L.
        Pheochromocytoma crisis: the use of magnesium sulfate.
        Anesth Analg. 2004; 99: 680-686
        • Tucker K.L.
        • Hannan M.T.
        • Chen H.
        • Cupples L.A.
        • Wilson P.W.
        • Kiel D.P.
        Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women.
        Am J Clin Nutr. 1999; 69: 727-736
        • Thwaites C.L.
        • Yen L.M.
        • Loan H.T.
        • et al.
        Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial.
        Lancet. 2006; 368: 1436-1443
        • Scheibe F.
        • Haupt H.
        • Mazurek B.
        • Konig O.
        Therapeutic effect of magnesium on noise-induced hearing loss.
        Noise Health. 2001; 3: 79-84
        • Facchinetti F.
        • Borella P.
        • Sances G.
        • Fioroni L.
        • Nappi R.E.
        • Genazzani A.R.
        Oral magnesium successfully relieves premenstrual mood changes.
        Obstet Gynecol. 1991; 78: 177-181
      1. U.S. Preventive Services Task Froce. Grade Definitions.http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm [website accessed June 2012].

        • Fawcett W.J.
        • Haxby E.J.
        • Male D.A.
        Magnesium: physiology and pharmacology.
        Br J Anaesth. 1999; 83: 302-320
      2. Institute of Medicine. Food and Nutrition Board. Dietary reference intakes: calcium, phosphorus, magnesium, vitamin D and fluoride. Washington, DC: National Academy Press; 1999.

        • Ford E.S.
        • Mokdad A.H.
        Dietary magnesium intake in a national sample of U.S. adults.
        J Nutr. 2003; 133: 2879-2882
        • Kayne L.H.
        • Lee D.B.
        Intestinal magnesium absorption.
        Miner Electrolyte Metab. 1993; 19: 210-221
        • Allgrove J.
        • Adami S.
        • Fraher L.
        • Reuben A.
        • O’Riordan J.L.H.
        Hypomagnesaemia: studies of parathyroid hormone secretion and function.
        Clin Endocrinol (Oxf). 1984; 21: 435-449
        • Rude R.K.
        • Ryzen E.
        TmMg and renal Mg threshold in normal man in certain pathophysiologic conditions.
        Magnesium. 1986; 5: 273-281
        • Wacker W.E.C.
        • Parisi A.F.
        Magnesium metabolism.
        N Engl J Med. 1968; 278: 658-663
        • Swaminathan R.
        Magnesium metabolism and its disorders.
        Clin Biochem Rev. 2003; 24: 47-66
        • Onishi S.
        • Yoshino S.
        Cathartic-induced fatal hypermagnesemia in the elderly.
        Int Med. 2006; 45: 207-210
        • Nassar A.H.
        • Sakhel K.
        • Maarouf H.
        • Naassan G.R.
        • Usta I.M.
        Adverse maternal and neonatal outcome of prolonged magnesium sulfate tocolysis.
        Acta Obstet Gynecol Scand. 2006; 85: 1099-1103
        • Lu J.F.
        • Nightingale C.H.
        Magnesium sulphate regimens in eclampsia and preeclampsia: pharmacokinetic properties.
        Clin Pharmacokinet. 2000; 38: 305-314
        • Morisaki H.
        • Yamamoto S.
        • Morita Y.
        • Kotake Y.
        • Ochiai R.
        • Takeda J.
        Hypermagnesemia-induced cardiopulmonary arrest before induction of anesthesia for emergency cesarean section.
        J Clin Anesth. 2000; 12: 224-226
        • Blake J.A.
        The treatment of tetanus by magnesium sulphate.
        Ann Surg. 1906; 44: 367-373
        • Lazard E.M.
        A preliminary report on the intravenous use of magnesium sulphate in puerperal eclampsia.
        Am J Obstet Gynecol. 1925; 9: 178-188
        • Sibai B.M.
        Hypertension in pregnancy.
        in: Gabbe S.G. Niebyl J.R. Simpson J.L. Obstetrics: normal and problem pregnancies. 3rd ed. Churchill Livingstone, New York1996: 935-996
      3. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: final data for 2007. National center for health statistics. Natl Vital Stat Rep, 2010;58(19).

      4. Centre for Maternal and Child Enquiries (CMACE). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006–08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG, 2011;118(Suppl 1):1–203.

        • James M.F.M.
        The use of magnesium sulfate in the anesthetic management of pheochromocytoma.
        Anesthesiology. 1985; 62: 188-189
      5. Royal College of Obstetricians and Gynaecologists (ACOG). The management of severe pre-eclampsia/eclampsia. RCOG Guideline No. 10(A). March 2006. Reviewed 2010.

        • Turner J.A.
        Diagnosis and management of pre-eclampsia: an update.
        Int J Women’s Health. 2010; 2: 327-337
        • Altura B.M.
        • Altura B.T.
        • Carella A.
        • Gebrewold A.
        • Murakawa T.
        • Nishio A.
        Mg2+-Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels.
        Can J Physiol Pharmacol. 1987; 65: 729-745
        • Goldkrand J.W.
        • Fuentes A.M.
        The relation of angiotensin-converting enzyme to the pregnancy-induced hypertension-pre-eclampsia syndrome.
        Am J Obstet Gynecol. 1986; 154: 792-800
        • James M.F.
        Magnesium in obstetrics.
        Best Pract Res Clin Obstet. 2010; 23: 327-337
        • Euser A.G.
        • Cipolla M.J.
        Magnesium sulfate for the treatment of eclampsia: a brief review.
        Stroke. 2009; 40: 1169-1175
        • Livingstone J.C.
        • Livingstone L.W.
        • Ramsey R.
        • Mabie B.C.
        • Sibai B.M.
        Magnesium sulfate in women with mild pre-eclampsia: a randomised controlled trial.
        Obstet Gynecol. 2003; 101: 217-220
        • Witlin A.G.
        • Friedman S.A.
        • Sibai B.M.
        The effect of magnesium sulfate therapy on the duration of labor in women with mild pre-eclampsia at term: a randomized, double blind, placebo-controlled trial.
        Am J Obstet Gynecol. 1997; 176: 623-627
        • Scott J.R.
        Magnesium sulfate for mild pre-eclampsia.
        Obstet Gynecol. 2003; 101: 213
        • Alexander J.M.
        • McIntire D.D.
        • Leveno K.J.
        • Cunningham F.G.
        Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension.
        Obstet Gynecol. 2006; 108: 826-832
        • Cahill A.G.
        • Macones G.A.
        • Odibo A.O.
        • Stamilio D.M.
        Magnesium for seizure prophylaxis in patients with mild pre-eclampsia.
        Obstet Gynecol. 2007; 110: 601-607
        • Moodley J.
        • Moodley V.V.
        Prophylactic anticonvulsant therapy in hypertensive crises of pregnancy – the need for a large randomized trial.
        Hypertens Pregnancy. 1994; 13: 245-252
        • Magpie Trial Collaborative Group
        Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.
        Lancet. 2002; 359: 1877-1890
        • Sibai B.M.
        Magnesium sulfate prophylaxis in pre-eclampsia: lessons learned from recent trials.
        Am J Obstet Gynecol. 2004; 190: 1520-1526
        • Coetzee E.J.
        • Dommisee J.
        • Anthony J.
        A randomized controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia.
        Br J Obstet Gynaecol. 1998; 105: 300-303
      6. Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2010;11:CD000025.

        • Witlin A.G.
        • Sibai B.M.
        Randomized trials for prevention and treatment of eclamptic convulsions.
        in: Sibai B.M. Hypertensive disorders in women. Saunders, Philadelphia2001: 221-227
        • Belfort M.A.
        • Anthony J.
        • Saade G.R.
        • Allen J.C.
        A Comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
        N Engl J Med. 2003; 348: 304-311
        • The Eclampsia Trial Collaborative Group
        Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial.
        Lancet. 1995; 345: 1455-1463
        • Hall D.G.
        • McGaughey H.S.
        • Corey E.L.
        • Thornton W.N.
        The effects of magnesium therapy on the duration of labor.
        Am J Obstet Gynecol. 1959; 78: 27-32
        • Friedman S.A.
        • Lim K.
        • Baker C.A.
        • Repke J.T.
        Phenytoin versus magnesium sulfate in pre-eclampsia: a pilot study.
        Am J Perinatol. 1993; 10: 233-238
        • Atkinson M.W.
        • Guinn D.
        • Owen J.
        • Hauth J.C.
        Does magnesium sulfate affect the length of labor induction in women with pregnancy-associated hypertension?.
        Am J Obstet Gynecol. 1995; 173: 1219-1222
      7. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002;4:CD001060.

        • Nelson K.B.
        • Grether J.K.
        Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?.
        Pediatrics. 1995; 95: 263-269
      8. Paneth N, Jetton J, Pinto-Martin J, Susser M, and the Neonatal Brain Hemorrhage Study Analysis Group. Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants. Pediatrics 1997;99:e1.

        • Mittendorf R.
        • Dambrosia J.
        • Pryde P.G.
        • et al.
        Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
        Am J Obstet Gynecol. 2002; 186: 1111-1118
        • Crowther C.A.
        • Hiller J.E.
        • Doyle L.W.
        • Haslam R.R.
        Effect of magnesium sulfate given for neuroprotection before preterm birth.
        JAMA. 2003; 290: 2669-2676
        • Marret S.
        • Marpeau L.
        • Zupan-Simuek V.
        • et al.
        Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial.
        BJOG. 2007; 114: 310-318
        • Rouse D.J.
        • Hirtz D.G.
        • Thorn E.
        • et al.
        A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.
        N Engl J Med. 2008; 359: 895-905
      9. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev, 2009:1:CD004661.

        • ACOG Committee on Obstetric Practice
        Magnesium sulfate before anticipated preterm birth for neuroprotection.
        Committee Opin Obstet Gynecol. 2010; 115: 669-671
        • Bucklin B.
        • Hawkins J.L.
        • Anderson J.R.
        • Ullrich F.A.
        Obstetric anesthesia workforce survey: twenty year update.
        Anesthesiology. 2005; 103: 645-653
        • Fox E.J.
        • Sklar G.S.
        • Hill C.H.
        • Villanueva R.
        • King B.D.
        Complications related to the pressor response to endotracheal intubation.
        Anesthesiology. 1977; 47: 524-525
        • James M.F.M.
        • Beer R.E.
        • Esser J.D.
        Intravenous magnesium sulphate inhibits catecholamine release associated with tracheal intubation.
        Anesth Analg. 1989; 68: 772-776
        • Allen R.W.
        • James M.F.M.
        • Uys P.C.
        Attenuation of the pressor response to tracheal intubation in hypertensive proteinuric patients by lignocaine, alfentanil and magnesium sulphate.
        Br J Anaesth. 1991; 66: 216-223
        • Ashton W.B.
        • James M.F.M.
        • Janicki P.
        • Uys P.C.
        Attenuation of the pressor response to tracheal intubation by magnesium sulphate with and without alfentanil in hypertensive proteinuric patients undergoing caesarean section.
        Br J Anaesth. 1991; 67: 741-747
        • Robins K.
        • Lyons G.
        Intraoperative awareness during general anesthesia for cesarean delivery.
        Anesth Analg. 2009; 109: 886-890
        • Telci L.
        • Esen F.
        • Akcora D.
        • Erden T.
        • Canbolat A.T.
        • Akpir K.
        Evaluation of effects of magnesium sulphate in reducing intraoperative anaesthetic requirements.
        Br J Anaesth. 2002; 89: 594-598
        • Altan A.
        • Turgut N.
        • Yildiz F.
        • Turkmen A.
        • Ustun H.
        Effects of magnesium sulphate and clonidine on propofol consumption, haemodynamics and postoperative recovery.
        Br J Anaesth. 2005; 94: 438-441
        • Durmus M.
        • But A.K.
        • Erdem T.B.
        • Ozpolat Z.
        • Ersoy M.O.
        The effects of magnesium sulphate on sevoflurane minimum alveolar concentrations and haemodynamic responses.
        Eur J Anaesthesiol. 2006; 23: 54-59
        • Lee D.H.
        • Kwon I.C.
        Magnesium sulphate has beneficial effects as an adjuvant during general anaesthesia for caesarean section.
        Br J Anaesth. 2009; 103: 861-866
        • Czarnetzki C.
        • Lysakowski C.
        • Elia N.
        • Tramer M.R.
        Time course of rocuronium-induced neuromuscular block after pre-treatment with magnesium sulphate: a randomised study.
        Acta Anaesthesiol Scand. 2010; 54: 299-306
        • James M.F.M.
        Magnesium in obstetric anesthesia.
        Int J Obstet Anesth. 1998; 7: 115-123
        • Yoshida A.
        • Itoh Y.
        • Nagaya K.
        • et al.
        Prolonged relaxant effects of vecuronium in patients with deliberate hypermagnesemia: time for caution in caesarean section.
        J Anesth. 2006; 20: 33-35
        • Schreiber J.U.
        • Lysakowski C.
        • Fuchs-Buder T.
        • Tramer M.R.
        Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis of randomized trials.
        Anesthesiology. 2005; 103: 877-884
        • Woolf C.J.
        • Thompson S.W.
        The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states.
        Pain. 1991; 44: 293-299
        • Omote K.
        • Sonoda H.
        • Kawamata M.
        • Iwasaki H.
        • Namiki A.
        Potentiation of antinociceptive effects of morphine by calcium-channel blockers at the level of the spinal cord.
        Anesthesiology. 1993; 79: 746-752
        • Koinig H.
        • Wallner T.
        • Marhofer P.
        • Andel H.
        • Horauf K.
        • Mayer N.
        Magnesium sulfate reduces intra- and postoperative analgesic requirements.
        Anesth Analg. 1998; 87: 206-210
        • Lysakowski C.
        • Dumont L.
        • Czarnetzki C.
        • Tramer M.
        Magnesium as an adjuvant to postoperative analgesia: a systematic review of randomised trials.
        Anesth Analg. 2007; 104: 1532-1539
        • Buvanendran A.
        • McCarthy R.J.
        • Kroin J.S.
        • Leond W.
        • Perry P.
        • Tuman K.J.
        Intrathecal magnesium prolongs fentanyl analgesia: a prospective randomized controlled trial.
        Anaesth Analg. 2002; 95: 661-666
        • Malleeswaran S.
        • Panda N.
        • Mathew P.
        • Bagga R.
        A randomised study of magnesium sulphate as an adjuvant to intrathecal bupivacaine in patients with mild pre-eclampsia undergoing caesarean section.
        Int J Obstet Anesth. 2010; 19: 161-166
        • Sun J.
        • Wu X.
        • Xu X.
        • Jin L.
        • Han N.
        • Zhou R.
        A comparison of epidural magnesium and/or morphine with bupivacaine for postoperative analgesia after caesarean section.
        Int J Obstet Anesth. 2012; 21: 310-316
        • Yousef A.A.
        • Amr Y.M.
        The effect of adding magnesium sulphate to epidural bupivacaine and fentanyl in elective caesarean section using combined spinal-epidural anaesthesia: a prospective double blind randomised study.
        Int J Obstet Anesth. 2010; 19: 401-404
        • Sullivan J.T.
        • Higgins N.
        • Toledo P.
        • Scavobe B.M.
        • McCarthy R.J.
        • Wong C.A.
        The effect of intravenous magnesium therapy on the duration of intrathecal fentanyl labor analgesia.
        Int J Obstet Anesth. 2012; 21: 212-216